Nurix Therapeutics, Inc. (NRIX)

NASDAQ: NRIX · Real-Time Price · USD

15.19

-0.62 (-3.92%)

Mar 3, 2026, 10:18 AM EST - Market open

Revenue by Segment

Financials in millions USD. Fiscal year is December - November.

Millions USD. Fiscal year is Dec - Nov.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020	Nov '19 Nov 30, 2019	Nov '18 Nov 30, 2018
Pharmaceuticals	83.98M	54.55M	76.99M	38.63M	29.75M
Pharmaceuticals Growth	53.95%	-29.15%	99.31%	29.84%	66.95%
Total	83.98M	54.55M	76.99M	38.63M	29.75M
Total Growth	53.95%	-29.15%	99.31%	29.84%	66.95%

Revenue by Geography

Financials in millions USD. Fiscal year is December - November.

Millions USD. Fiscal year is Dec - Nov.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020	Nov '19 Nov 30, 2019	Nov '18 Nov 30, 2018
United States	83.98M	54.55M	76.99M	38.63M	29.75M
United States Growth	53.95%	-29.15%	99.31%	29.84%	66.95%
Total	83.98M	54.55M	76.99M	38.63M	29.75M
Total Growth	53.95%	-29.15%	99.31%	29.84%	66.95%

Source: S&P Global Market Intelligence.